Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate superior intraocular pressure (IOP) control with
travoprost 0.004% / timolol 0.5% compared to beta-blocker monotherapy in participants with
open-angle glaucoma or ocular hypertension.